Kawasaki, Japan

Kunisuki Izawa

This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kunisuki Izawa: Innovator in Pharmaceutical Chemistry

Introduction

Kunisuki Izawa is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for producing optically active compounds. His work has implications for the production of important medicinal agents.

Latest Patents

Izawa holds a patent for a method of producing optically active phenylpropionic acid derivatives. The patent, titled "Method for producing optically active phenylpropionic acid derivative," describes a process that allows for the industrial production of N-(S-2-acetylthiomethyl-1-oxo-3-phenylpropyl)-glycine benzyl ester. This compound is useful as an enkephalin inhibitory agent or ACE inhibitory agent and can be produced at low cost through a series of chemical reactions.

Career Highlights

Izawa is associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His innovative approach to chemical synthesis has positioned him as a valuable asset in his field. With 1 patent to his name, he continues to contribute to advancements in pharmaceutical chemistry.

Collaborations

Throughout his career, Izawa has worked alongside talented colleagues, including Takayuki Suzuki and Takayuki Hamada. Their collaborative efforts have fostered an environment of innovation and creativity within their projects.

Conclusion

Kunisuki Izawa's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the development of medicinal compounds. His work not only enhances the efficiency of production methods but also supports the advancement of healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…